Table 2 HPV types in HPV-positive invasive cervical cancers from the U.S., Botswana, and Kenya
HPV type | U.S., N = 46 | Botswana, N = 136 | Kenya, N = 146 | p-value |
|---|---|---|---|---|
High-risk (HR) type distribution | ||||
HR-HPV | 46 (100 %) | 130 (95.6 %) | 145 (99.3 %) | 0.085 |
HPV 16 | 40 (87.0 %) | 58 (42.7 %) | 118 (80.8 %) | <0.001 |
HPV 18 | 4 (8.7 %) | 32 (23.5 %) | 28 (19.2 %) | 0.089 |
HPV 26 | 0 | 5 (3.7 %) | 0 | 0.033 |
HPV 31 | 1 (2.2 %) | 5 (3.7 %) | 2 (1.4 %) | 0.430 |
HPV 33 | 1 (2.2 %) | 7 (5.2 %) | 2 (1.4 %) | 0.143 |
HPV 35 | 0 | 8 (5.9 %) | 1 (0.7 %) | 0.021 |
HPV 39 | 0 | 6 (4.4 %) | 1 (0.7 %) | 0.085 |
HPV 45 | 3 (6.5 %) | 12 (8.8 %) | 9 (6.2 %) | 0.676 |
HPV 51 | 0 | 3 (2.2 %) | 0 | 0.123 |
HPV 52 | 0 | 4 (2.9 %) | 0 | 0.081 |
HPV 53 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 56 | 0 | 0 | 0 | - |
HPV 58 | 0 | 2 (1.5 %) | 2 (1.4 %) | 1.000 |
HPV 59 | 0 | 2 (1.5 %) | 2 (1.4 %) | 1.000 |
HPV 66 | 0 | 4 (2.9 %) | 0 | 0.081 |
HPV 67 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 68 | 0 | 2 (1.5 %) | 0 | 0.432 |
HPV 69 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 70 | 0 | 0 | 0 | - |
HPV 73 | 0 | 0 | 1 (0.7 %) | 1.000 |
HPV 82 | 0 | 2 (1.5 %) | 2 (1.4 %) | 1.000 |
HPV IS39 | 0 | 0 | 0 | - |
Low-risk (LR) type distribution | ||||
LR-HPV | 0 | 12 (8.8 %) | 3 (2.1 %) | 0.007 |
HPV 6 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 11 | 0 | 1 (0.7 %) | 3 (2.1 %) | 0.795 |
HPV 40 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 42 | 0 | 0 | 0 | - |
HPV 54 | 0 | 0 | 0 | - |
HPV 55 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 61 | 0 | 0 | 0 | - |
HPV 62 | 0 | 0 | 0 | - |
HPV 71 | 0 | 0 | 0 | - |
HPV 72 | 0 | 0 | 0 | - |
HPV 81 | 0 | 1 (0.7 %) | 0 | 0.555 |
HPV 83 | 0 | 2 (1.5 %) | 0 | 0.432 |
HPV 84 | 0 | 6 (4.4 %) | 0 | 0.017 |